Jazz Music and Mindfulness for Chronic Pain

Chronic Pain Clinical Trial

Official title:

Jazz Music and Mindfulness for Chronic Pain

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05979012
• Other study ID #: #3454
• Status: Not yet recruiting
• Phase: N/A
• Start date: August 2023
• Est. completion date: October 2023

Study information

• Verified date: July 2023
• Source: University of California, Irvine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Chronic pain, including spinal pain and osteoarthritis, is the leading cause of years lived with disability world-wide and the costliest health condition in the U.S. today. Compounding these concerns, opioid analgesics remain the primary pharmacological treatment for chronic pain. An estimated 21-29% of chronic pain patients receiving long-term opioid therapy develop opioid misuse, and opioid misuse portends addiction and overdose. Clearly, chronic pain patients need better, non-addictive treatment options designed to reverse the downward spiral of chronic pain.

Description:

Group Assignments

Participants will be randomized into one of three groups.

1. Jazz Group 1: Participants in this group will watch an introduction to jazz appreciation video prior to the 4-week intervention.

2. Jazz Group 2 (Mindful Jazz) Group: Participants in this group will watch a video on mindful listening to jazz.

3. Music Waitlist Group: Participants in this group will serve as a control and will not receive any intervention until the study is completed. They will complete a baseline survey and a follow-up survey at four weeks. Some videos will be sent to this group after the study is completed, without tracking their usage.

Intervention

All groups will complete a baseline and 4-week follow-up survey.

Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.They will have access to electronic audio recordings, with the order of listening labeled for each day. It is up to them if they want to listen to the daily recordings.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 90
• Est. completion date: October 2023
• Est. primary completion date: October 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Are 18+

2. Live in the US

3. Are an English-proficient adult with a chronic pain diagnosis (no restrictions placed on type)

4. Have a pain rating of four or greater in average pain on a 0-10 numeric rating scale in the preceding week

5. Have had pain for at least 3 months and for at least 15 days in the preceding 30 days

6. Have moderate to severe anxiety based on GAD-7

Exclusion Criteria:

1. Are currently using or have used prescription opioids in the past 3 months to minimize a known treatment confound and increase sample homogeneity

2. Have a current cancer diagnosis

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Behavioral:
• MIndfulness Listening to Jazz
All groups will complete a baseline and 4-week follow-up survey. Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.It is up to them if they want to listen to the daily recordings.
• Listening to Jazz
All groups will complete a baseline and 4-week follow-up survey. Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.They will have access to electronic audio recordings, with the order of listening labeled for each day. The recordings will increase gradually throughout the study, starting with about 10 minutes each day in the first week and reaching 30 minutes each day in the final week. The schedule is as follows: Week 1= 10 minutes, Week 2= 15 minutes, Week 3= 20 minutes Week 4= 30 minutes. It is up to them if they want to listen to the daily recordings.

Locations

Country	Name	City	State
United States	University of California Irvine	Irvine	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain Self-Efficacy	Pain self-efficacy, which refers to participants' confidence in their ability to manage pain, will be assessed using the Pain Self-Efficacy Questionnaire.	4 weeks
Primary	Global Satisfaction with Treatment	Participants' overall satisfaction with the treatment will be measured using the Patients' Global Impression of Change (PGIC) scale.	4 weeks
Secondary	Pain Intensity	The PEG scale will be used to assess the magnitude of pain sensations experienced by participants in the past week.	4 weeks
Secondary	Pain Interference	The degree of pain interference in different aspects of participants' lives will be evaluated using the PEG scale.	4 weeks